» Articles » PMID: 37918889

Getting off Tract: Contributions of Intraorgan Microbiota to Cancer in Extraintestinal Organs

Overview
Journal Gut
Specialty Gastroenterology
Date 2023 Nov 2
PMID 37918889
Authors
Affiliations
Soon will be listed here.
Abstract

The gastrointestinal ecosystem has received the most attention when examining the contributions of the human microbiome to health and disease. This concentration of effort is logical due to the overwhelming abundance of microbes in the gut coupled with the relative ease of sampling compared with other organs. However, the intestines are intimately connected to multiple extraintestinal organs, providing an opportunity for homeostatic microbial colonisation and pathogenesis in organs traditionally thought to be sterile or only transiently harbouring microbiota. These habitats are challenging to sample, and their low microbial biomass among large amounts of host tissue can make study challenging. Nevertheless, recent findings have shown that many extraintestinal organs that are intimately linked to the gut harbour stable microbiomes, which are colonised from the gut in selective manners and have highlighted not just the influence of the bacteriome but that of the mycobiome and virome on oncogenesis and health.

Citing Articles

Antitumor potentials of onco-microbial in Chinese patients with pancreatic cancer.

Gao Y, Zhou D, Lu Y, Yang L, Gong X, Chen M Heliyon. 2024; 10(24):e40890.

PMID: 39720030 PMC: 11665473. DOI: 10.1016/j.heliyon.2024.e40890.


Natural compounds modulate the mechanism of action of tumour-associated macrophages against colorectal cancer: a review.

Yuan W, Zhang J, Chen H, Zhuang Y, Zhou H, Li W J Cancer Res Clin Oncol. 2024; 150(11):502.

PMID: 39546016 PMC: 11568041. DOI: 10.1007/s00432-024-06022-8.

References
1.
Finlay B, Goldszmid R, Honda K, Trinchieri G, Wargo J, Zitvogel L . Can we harness the microbiota to enhance the efficacy of cancer immunotherapy?. Nat Rev Immunol. 2020; 20(9):522-528. DOI: 10.1038/s41577-020-0374-6. View

2.
Amos G, Logan A, Anwar S, Fritzsche M, Mate R, Bleazard T . Developing standards for the microbiome field. Microbiome. 2020; 8(1):98. PMC: 7320585. DOI: 10.1186/s40168-020-00856-3. View

3.
Sepich-Poore G, Zitvogel L, Straussman R, Hasty J, Wargo J, Knight R . The microbiome and human cancer. Science. 2021; 371(6536). PMC: 8767999. DOI: 10.1126/science.abc4552. View

4.
Arunsan P, Ittiprasert W, Smout M, Cochran C, Mann V, Chaiyadet S . Programmed knockout mutation of liver fluke granulin attenuates virulence of infection-induced hepatobiliary morbidity. Elife. 2019; 8. PMC: 6355195. DOI: 10.7554/eLife.41463. View

5.
Jusakul A, Cutcutache I, Yong C, Lim J, Huang M, Padmanabhan N . Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. Cancer Discov. 2017; 7(10):1116-1135. PMC: 5628134. DOI: 10.1158/2159-8290.CD-17-0368. View